tiprankstipranks
Trending News
More News >
Pro-Dex (PDEX)
NASDAQ:PDEX
Advertisement

Pro-Dex (PDEX) Price & Analysis

Compare
106 Followers

PDEX Stock Chart & Stats


Bulls Say, Bears Say

Bulls Say
Analyst ConfidenceAnalyst maintains a BUY rating and raises the 12-month price target to $52, reflecting confidence in the company’s strong growth potential.
Product DiversificationPro-Dex is diversifying its customer base and product lines by developing new devices, which is seen as a positive move.
Revenue GrowthPro-Dex reported fiscal Q2 2025 revenue of $16.8 million, a 33% increase year-over-year, exceeding estimates.
Bears Say
Operational ChallengesThe company experienced a large jump in backlog, with Q1 backlog rising to $57 million from $20 million in the previous quarter.

Pro-Dex News

PDEX FAQ

What was Pro-Dex’s price range in the past 12 months?
Pro-Dex lowest stock price was $26.28 and its highest was $70.26 in the past 12 months.
    What is Pro-Dex’s market cap?
    Pro-Dex’s market cap is $109.57M.
      When is Pro-Dex’s upcoming earnings report date?
      Pro-Dex’s upcoming earnings report date is Oct 30, 2025 which is in 25 days.
        How were Pro-Dex’s earnings last quarter?
        Pro-Dex released its earnings results on Sep 04, 2025. The company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.47 by -$0.11.
          Is Pro-Dex overvalued?
          According to Wall Street analysts Pro-Dex’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Pro-Dex pay dividends?
            Pro-Dex does not currently pay dividends.
            What is Pro-Dex’s EPS estimate?
            Pro-Dex’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Pro-Dex have?
            Pro-Dex has 3,261,979 shares outstanding.
              What happened to Pro-Dex’s price movement after its last earnings report?
              Pro-Dex reported an EPS of $0.36 in its last earnings report, missing expectations of $0.47. Following the earnings report the stock price went down -16.506%.
                Which hedge fund is a major shareholder of Pro-Dex?
                Among the largest hedge funds holding Pro-Dex’s share is Covalent Partners Llc. It holds Pro-Dex’s shares valued at 0.

                  Company Description

                  Pro-Dex

                  Pro-Dex, Inc. (PDEX) is a leading manufacturer of precision engineered products and systems, primarily serving the medical device, dental, and industrial automation sectors. The company specializes in developing and producing advanced motion control and power solutions, including servo motors, drives, and other components that enhance the performance of medical instruments and equipment. Pro-Dex's core offerings also include contract manufacturing services, which provide tailored solutions to meet the specific needs of its clients across various industries.

                  Pro-Dex (PDEX) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Utah Medical Products
                  Microbot Medical
                  REPRO-MED Systems
                  Sharps Technology, Inc.
                  Jin Medical International Ltd.

                  Ownership Overview

                  44.31%6.22%5.03%36.84%
                  44.31% Insiders
                  5.03% Other Institutional Investors
                  36.84% Public Companies and
                  Individual Investors

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis